In Vivo Imaging of the Innate Immune System in the Pancreas in New‐Onset and Long‐Standing Type 1 Diabetes
Diabetes, Obesity and Metabolism · 2026-06 · 28 (6) · 4876-4883
DOI: 10.1111/dom.70672 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 23.03.2026. Verfasst von Ebrahim Anvari und 9 weiteren Autor:innen. Beteiligte Einrichtung: Science for Life Laboratory, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Immunity, Innate, Positron-Emission Tomography, Pancreas. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Diabetesfonden, Science for Life Laboratory, Barndiabetesfonden, Uppsala Diabetes Center, the Swedish Research Council (Vetenskapsrådet).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objective
Type 1 diabetes (T1D) is an autoimmune disease, but knowledge of immune cell infiltration in the human pancreas is limited due to the risks associated with pancreatic biopsies. This study aimed to evaluate the feasibility of imaging innate immune cells in vivo using positron emission tomography (PET).
Methods
We used PET tracers targeting M1 macrophages ([ 68 Ga]‐DOTATATE) and neutrophil elastase ([ 11 C]‐NES) to assess pancreatic immune cell infiltration in individuals with new‐onset T1D ( n = 4), long‐standing T1D ( n = 6), and healthy controls ( n = 6).
Results
Both tracers enabled visualisation and quantification of pancreatic uptake. Uptake of both [ 68 Ga]‐DOTATATE and [11C]‐NES was not increased in new‐onset T1D compared to healthy controls but was elevated in individuals with long‐standing T1D.
Discussion
PET imaging of innate immune cells in the pancreas is feasible. While no increased macrophage or neutrophil activity was observed in new‐onset T1D, increased tracer uptake in long‐standing T1D may reflect late‐stage inflammatory processes and fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
- Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
- Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden.
- Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
- Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
- PET Center, Akademiska Sjukhuset, Uppsala, Sweden.
ORCID-Profile: Hongchao Zhang
Förderung
- Diabetesfonden, Science for Life Laboratory
- Barndiabetesfonden, Uppsala Diabetes Center
- the Swedish Research Council (Vetenskapsrådet)
- Swedish Cancer Society/(Cancerfonden)
- Diabetesfonden
- Barndiabetesfonden
- Vetenskapsrådet
- Cancerfonden
Zitieren
APA
Anvari, E., Zhang, H., Hill, H., Missima, N. G., Liss, P., Velikyan, I., Antoni, G., Korsgren, O., Espes, D., & Eriksson, O. (2026). In Vivo Imaging of the Innate Immune System in the Pancreas in New‐Onset and Long‐Standing Type 1 Diabetes. Diabetes, Obesity and Metabolism, 28(6), 4876-4883. https://doi.org/10.1111/dom.70672
Vancouver
Anvari E, Zhang H, Hill H, Missima NG, Liss P, Velikyan I, et al. In Vivo Imaging of the Innate Immune System in the Pancreas in New‐Onset and Long‐Standing Type 1 Diabetes. Diabetes, Obesity and Metabolism. 2026;28(6):4876-4883. doi:10.1111/dom.70672
BibTeX
@article{Anvari2026,
author = {Anvari, Ebrahim and Zhang, Hongchao and Hill, Henrik and Missima, Nathalia Guarienti and Liss, Per and Velikyan, Irina and Antoni, Gunnar and Korsgren, Olle and Espes, Daniel and Eriksson, Olof},
title = {In Vivo Imaging of the Innate Immune System in the Pancreas in New‐Onset and Long‐Standing Type 1 Diabetes},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
volume = {28},
number = {6},
pages = {4876--4883},
doi = {10.1111/dom.70672}
}
EUVIMED